ImmuCell Corporation Revenue and Competitors

Portland, ME USA

Location

$14.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ImmuCell Corporation's estimated annual revenue is currently $7.5M per year.(i)
  • ImmuCell Corporation's estimated revenue per employee is $166,667
  • ImmuCell Corporation's total funding is $14.2M.

Employee Data

  • ImmuCell Corporation has 45 Employees.(i)
  • ImmuCell Corporation grew their employee count by 13% last year.

ImmuCell Corporation's People

NameTitleEmail/Phone
1
VP Sales & MarketingReveal Email/Phone
2
VP/Director/Chief Scientific OfficerReveal Email/Phone
3
Senior Director QualityReveal Email/Phone
4
Territory ManagerReveal Email/Phone
5
Vaccine ManagerReveal Email/Phone
6
Sales and Marketing Midwestern Regional ManagerReveal Email/Phone
7
Commercial Research and Technical Services VeterinarianReveal Email/Phone
8
Manufacturing AssociateReveal Email/Phone
9
Senior Vaccine Technical SpecialistReveal Email/Phone
10
Vaccine Manufacturing AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3140M10898N/AN/AN/A
#2
$1.9M129%N/AN/A
#3
$41.4M267-5%N/AN/A
#4
$1.4M90%N/AN/A
#5
$1.6M100%N/AN/A
#6
$508.2M32791%N/AN/A
#7
$1.4M90%N/AN/A
#8
$29.9M19324%N/AN/A
#9
$26M1682%N/AN/A
#10
$0.8M50%N/AN/A
Add Company

What Is ImmuCell Corporation?

ImmuCell Corporation is a biotechnology company serving veterinarians and producers in the dairy and beef industry with proprietary products that improve animal health and productivity. From its inception, the Company has engaged in the research and development of infectious disease diagnostic tests and products for therapeutic and preventive use against certain infectious diseases in animals and humans. The Company's product offerings include First Defense for scours prevention; Intelligent Mastitis Management Program for the management of mastitis; test kits for diagnosing infectious disease, and other animal health products.

keywords:N/A

$14.2M

Total Funding

45

Number of Employees

$7.5M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ImmuCell Corporation News

2022-04-13 - Head to Head Review: Navidea Biopharmaceuticals (NYSE ...

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of...

2022-04-06 - ImmuCell Announces Record Preliminary, Unaudited Sales ...

PORTLAND, Maine, April 11, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal...

2022-03-22 - IMMUCELL CORP /DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)

IMMUCELL CORP /DE/ MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) · The following discussion...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A4518%N/A
#2
$9.7M452%N/A
#3
$11.6M45-22%N/A
#4
$5.9M45-8%N/A
#5
$3.5M450%N/A